TRIM33 and dermatomyositis: This study was designed to evaluate the magnetic resonance imaging (MRI) patterns of the lower limb muscles in dermatomyositis (DM) with anti‐transcriptional intermediate factor 1‐γ (anti‐TIF1‐γ) antibody.